Back to search

Peptide record

TPDB10974

Pep27 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10974
Pep27
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 SATPdb dbACP iACP-DRLF pep-lab Antifungipept ToxinPred 3.0
standard
No
A 27-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
MRKEFHNVLSSGQLLADKRPARDYNRK
Physicochemical Analysis
C139H229N47O40S1
CITW
R
3230.70
10.86
8
3
9
+4
9.54
-1.293
61.48
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
46.12
6
Residue Composition
number
2
A
4
R
2
N
2
D
0
C
1
E
1
Q
1
G
1
H
0
I
3
L
3
K
1
M
1
F
1
P
2
S
0
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 2 R: 4 N: 2 D: 2 C: 0 E: 1 Q: 1 G: 1 H: 1 I: 0 L: 3 K: 3 M: 1 F: 1 P: 1 S: 2 T: 0 W: 0 Y: 1 V: 1
Chemical Descriptors
27
C139H229N47O40S1
3230.70
10.86
+4
9.54
-1.293
Free
L
Linear
Free
Anticancer
S. pneumoniae
Evidence Records 6 records
Evidence 1 Activity

Activity

Not Available
Anticancer

Target

Leukemia Cancer
AML-2
Blood

Assay & Model

MTT/MTS assay
14.54-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50= >70 µM
Anticancer
>70 µM

Target

Leukemia Cancer
HL-60
Blood

Assay & Model

MTT/MTS assay
14.54-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005
Evidence 3 Activity

Activity

IC50
IC50=>70 µM
Anticancer
>70 µM

Target

Blood Cancer
Jurkat
Blood

Assay & Model

MTT/MTS assay
14.54-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005
Evidence 4 Activity

Activity

IC50
IC50= >70 µM
Anticancer
>70 µM

Target

Gastric Cancer
SNU-601
Stomach

Assay & Model

MTT/MTS assay
14.54-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005
Evidence 5 Activity

Activity

IC50
IC50= >70 µM
Anticancer
>70 µM

Target

Breast Cancer
MCF-7
Breast

Assay & Model

MTT/MTS assay
14.54-Min

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2005
Evidence 6 Activity

Activity

0% Hemolysis
Toxicity
12.5 µM
Hemolytic Cytotoxic
0% Hemolysis | 12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Functional and structural characteristics of anticancer peptide Pep27 analogues. | Cancer Cell Int | 2005